Milan Radovich

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Small Cell Lung Cancer

Top Venues

Cancer research communications

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I Heath, Archana M Agarwal, Rana R McKay, Rohan Garje, Bruno R Bastos, Dave S B Hoon, Jacob J Orme, A Oliver Sartor, Ari M VanderWalde, Chadi Nabhan, George W Sledge, Eugene Shenderov, Scott M Dehm, Emil Lou, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies. Cancer research communications 4 (5) (2024)
Elisabeth I Heath, Gregory Dyson, Jennifer R Ribeiro, Joanne Xiu, Kelsey Poorman, Hirva Mamdani, Mohammad Najeeb Al-Hallak, Anthony Frank Shields, Jailan A Elayoubi, Ira S Winer, Frank Cameron Cackowski, Gary A Puckrein, Gilberto de Lima Lopes, Nathaniel L Jones, Ralph J Hauke, Samuel A Kareff, Milan Radovich, George W Sledge, David B Spetzler, Gregory A Vidal, John L Marshall
Health disparities among cancer patients who received molecular testing for biomarker-directed therapy. Cancer research communications (2024)
Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I Heath, Archana M Agarwal, Rana R McKay, Rohan Garje, Bruno R Bastos, Dave S B Hoon, Jacob J Orme, A Oliver Sartor, Ari M VanderWalde, Chadi Nabhan, George W Sledge, Eugene Shenderov, Scott M Dehm, Emil Lou, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target across Human Malignancies. Cancer research communications (2024)
Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I Heath, Archana M Agarwal, Rana R McKay, Rohan Garje, Bruno R Bastos, Dave S B Hoon, Jacob J Orme, A Oliver Sartor, Ari M VanderWalde, Chadi Nabhan, George W Sledge, Eugene Shenderov, Scott M Dehm, Emil Lou, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies. Cancer research communications 4 (5) (2024)
Fatemeh Ardeshir-Larijani, Bryan P Schneider, Sandra K Althouse, Milan Radovich, Ashiq Masood, Fabiana Perna, Huda Salman, Patrick J Loehrer
Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors. JCO precision oncology 7 (2023)
Fatemeh Ardeshir-Larijani, Bryan P Schneider, Sandra K Althouse, Milan Radovich, Ashiq Masood, Fabiana Perna, Huda Salman, Patrick J Loehrer
Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors. JCO precision oncology 7 (2023)
Tyler Shugg, Reynold C Ly, Elizabeth J Rowe, Santosh Philips, Mustafa A Hyder, Milan Radovich, Marc B Rosenman, Victoria M Pratt, John T Callaghan, Zeruesenay Desta, Bryan Paul Schneider, Todd C Skaar
Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers. JCO precision oncology 6 (2022)
Milan Radovich, Jeffrey P Solzak, Chao J Wang, Bradley A Hancock, Sunil S Badve, Sandra K Althouse, Steven M Bray, Anna Maria V Storniolo, Tarah Jean Ballinger, Bryan Paul Schneider, Kathy D Miller
Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Bryan Paul Schneider, Guanglong Jiang, Tarah Jean Ballinger, Fei Shen, Christopher Chitambar, Rita Nanda, Carla Falkson, Filipa C Lynce, Christopher M Gallagher, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Karen Daily, Reshma L Mahtani, Michael A Thompson, Robert Graham, Maureen E Cooper, Dean C Pavlick, Lee A Albacker, Jeffrey Gregg, Jeffrey P Solzak, Yu-Hsiang Chen, Casey L Bales, Erica L Cantor, Bradley A Hancock, Nawal Kassem, Paul Helft, Bert O'Neil, Anna Maria V Storniolo, Sunil S Badve, Kathy D Miller, Milan Radovich
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (4) (2021)